Lv3
360 积分 2025-08-27 加入
T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development
1年前
已完结
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia
1年前
已完结
Optimal approach to T-cell ALL
1年前
已关闭
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia
1年前
已完结
Obecabtagene Autoleucel: First Approval
1年前
已完结
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma
1年前
已完结
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
1年前
已完结
Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies
1年前
已完结
Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia
1年前
已完结
Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?
1年前
已完结
皖公网安备34019202002308
